Journal Articles
Publication Date
4-17-2024
Journal
Cell
Abstract
The gut microbiota has been found to play an important role in the progression of metabolic dysfunction-associated steatohepatitis (MASH), but the mechanisms have not been established. Here, by developing a click-chemistry-based enrichment strategy, we identified several microbial-derived bile acids, including the previously uncharacterized 3-succinylated cholic acid (3-sucCA), which is negatively correlated with liver damage in patients with liver-tissue-biopsy-proven metabolic dysfunction-associated fatty liver disease (MAFLD). By screening human bacterial isolates, we identified Bacteroides uniformis strains as effective producers of 3-sucCA both in vitro and in vivo. By activity-based protein purification and identification, we identified an enzyme annotated as β-lactamase in B. uniformis responsible for 3-sucCA biosynthesis. Furthermore, we found that 3-sucCA is a lumen-restricted metabolite and alleviates MASH by promoting the growth of Akkermansia muciniphila. together, our data offer new insights into the gut microbiota-liver axis that may be leveraged to augment the management of MASH.
Keywords
3-sucCA; BAS-suc; MAFLD; acylated bile acids; bile acid; biosynthesis; gut microbiota
Included in
Endocrinology, Diabetes, and Metabolism Commons, Gastroenterology Commons, Internal Medicine Commons, Public Health Commons